Veterinary/Animal Vaccines Market Size, Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others) and Regional Forecast, 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Veterinary/Animal Vaccines Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Veterinary/Animal Vaccines market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Veterinary/Animal Vaccines market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Veterinary/Animal Vaccines Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Veterinary/Animal Vaccines Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Veterinary/Animal Vaccines Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Market Players like Eli Lilly and Company, Elanco, Inc., and Intervet Inc. (Merck Animal Health) Will Ensure to Strengthen the Market Position with Respect to Providing Veterinary Vaccines Across the Globe
The veterinary vaccines market is dominated by some key companies due to their strong product portfolio, key strategic decisions and dominance of market share. These include a group of 4-5 key companies with wider geographic presence and continued R&D resulting in strong regulatory approvals. Anticipated executions of major strategic decisions such as Elancos acquisition of Bayers Animal Health division is further expected to consolidate the major revenue share amongst key companies.

List of Key Companies Profiled

  
Eli Lilly and Company
  
Boehringer Ingelheim International GmbH
  
Virbac
  
Intervet Inc. (Merck Animal Health)
  
Zoetis
  
Ceva
  
Elanco
  
Merial
  
Biovac
  
NEOGEN CORPORATION
  
ImmuCell Corporation

REPORT COVERAGE
The increased awareness on the impact of animal health on the human healthcare system and product launches based on advanced technologies is expected to increase the global veterinary vaccine market growth.

Along with this, the report provides an elaborative analysis of the global market dynamics and competitive landscape. Various key insights presented in the report are the prevalence of major animal diseases by countries, livestock and companion animal ownership patterns, recent industry developments such as mergers & acquisitions, the regulatory scenario in crucial countries, and technological advancements in animal immunization. Along with this other key insights includes an overview of novel vaccine delivery modes, key strategies adopted by market leaders, competitive landscape, and company profiles.

Report Scope & Segmentation

 Segmentation

By Product

  
Inactivated
  
Live Attenuated
  
Recombinant
  
Others

By Animal

  
Companion
  
Livestock

By Route of Administration

  
Oral
  
Parenteral
  
Others

By Distribution Channel

  
Veterinary Hospitals
  
Veterinary Clinics
  
Pharmacies & Drug Stores
  
Others

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

INDUSTRY DEVELOPMENT

January 2019: Boehringer Ingelheim launched the first vaccines produced in China for the vaccination of the swine called Ingelvac PRRS MLV for the China market

October 2018: MSD Animal Health announced the launch of the IDAL3G Twin, the first ever First Needle-Free and Intradermal Device with Two Injector Heads for the vaccination of the swine

December 2017: Zoetis announced the launch of the Vanguard CIV H3N2/H3N8 Vaccine, the latest vaccine in the companys canine influenza vaccine portfolio